Lithium: Difference between revisions
From Pharmacopedia
More actions
| [pending revision] | [pending revision] |
Medicine page v2: full MedTemplate build (PM-approved deploy 2026-06-03) |
Medicine page v3: citation-integrity correction, remove mismatched ref mcmaster2010, claim retained with citation-needed (PM-approved deploy 2026-06-03) |
||
| Line 25: | Line 25: | ||
'''Neurotransmitter effects.''' Lithium modulates serotonergic, dopaminergic, noradrenergic, and glutamatergic signaling, though it is not a receptor antagonist or reuptake inhibitor in the classical sense. Chronic lithium treatment increases serotonin synthesis and release in some brain regions, which may contribute to its antidepressant and anti-suicidal effects. It reduces dopaminergic supersensitivity, potentially accounting for its antimanic properties. Glutamate regulation, including effects on NMDA receptor signaling, has been proposed as relevant to its neuroprotective effects.{{citation needed}} | '''Neurotransmitter effects.''' Lithium modulates serotonergic, dopaminergic, noradrenergic, and glutamatergic signaling, though it is not a receptor antagonist or reuptake inhibitor in the classical sense. Chronic lithium treatment increases serotonin synthesis and release in some brain regions, which may contribute to its antidepressant and anti-suicidal effects. It reduces dopaminergic supersensitivity, potentially accounting for its antimanic properties. Glutamate regulation, including effects on NMDA receptor signaling, has been proposed as relevant to its neuroprotective effects.{{citation needed}} | ||
'''Circadian rhythm.''' Lithium lengthens the circadian period and inhibits GSK-3beta, which phosphorylates and degrades circadian clock proteins (Period, Cryptochrome). The resulting stabilization of circadian rhythms aligns with the circadian disruption seen in bipolar disorder and may be a primary mechanism of mood stabilization independent of classic neurotransmitter effects. | '''Circadian rhythm.''' Lithium lengthens the circadian period and inhibits GSK-3beta, which phosphorylates and degrades circadian clock proteins (Period, Cryptochrome). The resulting stabilization of circadian rhythms aligns with the circadian disruption seen in bipolar disorder and may be a primary mechanism of mood stabilization independent of classic neurotransmitter effects.{{citation needed}} | ||
The net picture: lithium acts through multiple simultaneously engaged mechanisms, none of which alone is sufficient to explain its clinical effects. This polypharmacy-within-a-molecule is consistent with the clinical observation that no other mood stabilizer fully replicates lithium's profile, particularly its unique anti-suicidal properties. | The net picture: lithium acts through multiple simultaneously engaged mechanisms, none of which alone is sufficient to explain its clinical effects. This polypharmacy-within-a-molecule is consistent with the clinical observation that no other mood stabilizer fully replicates lithium's profile, particularly its unique anti-suicidal properties. | ||